ReviewAntibodies (Basel, Switzerland)2019

Bispecific T-Cell Redirection versus Chimeric Antigen Receptor (CAR)-T Cells as Approaches to Kill Cancer Cells.

William R Strohl et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.